Negara: Amerika Serikat
Bahasa: Inggris
Sumber: NLM (National Library of Medicine)
ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R), .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) (.ALPHA.-TOCOPHEROL, DL- - UNII:7QWA1RIO01), FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8), CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204), BIOTIN (UNII: 6SO6U10H04) (BIOTIN - UNII:6SO6U10H04), IRON (UNII: E1UOL152H7) (IRON - UNII:E1UOL152H7), CUPRIC SULFATE (UNII: LRX7AJ16DT) (CUPRIC CATION - UNII:8CBV67279L), DOCUSATE SODIUM (UNII: F05Q2T2JA0)
Trigen Laboratories, LLC
ASCORBIC ACID
ASCORBIC ACID 500 mg
ORAL
This product is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy.
TL-HEM 150 is supplied in bottles of 90 caplets. PRODUCT CODE 13811-609-90
Dietary Supplement
TL-HEM 150- ASCORBIC ACID, .ALPHA.-TOCOPHEROL ACETATE, DL-, FOLIC ACID, CYANOCOBALAMIN, BIOTIN, IRON, CUPRIC SULFATE, AND DOCUSATE SODIUM TABLET, FILM COATED TRIGEN LABORATORIES, LLC ---------- TL-HEM 150 CAPLETS RX ONLY SUPPLEMENT FACTS TABLE Other Ingredients: Microcrystalline Cellulose, Coating (Polyvinyl Alcohol, Titanium Dioxide, Polyethylene Glycol, Talc, FD&C Yellow #6 Lake, FD&C Blue #2 Lake), Tripotassium Citrate, Citric Acid, Povidone K30, Acacia, Stearic Acid, Fumed Silica, and Magnesium Stearate. TL-HEM 150 is a hematinic multivitamin/multimineral dietary supplement used to improve the nutritional status of patients with iron deficiency. CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy. WARNINGS WARNING: ACCIDENTAL OVERDOSE OF IRON-CONTAINING PRODUCTS IS A LEADING CAUSE OF FATAL POISONING IN CHILDREN UNDER 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, CALL A DOCTOR OR POISON CONTROL CENTER IMMEDIATELY. PRECAUTIONS GENERAL: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Do not exceed recommended daily dose. Some patients affected with pernicious anemia may not respond to orally administered Vitamin B12 with intrinsic factor concentrate and there is no known way to predict which patients will respond. Periodic clinical assessment of pernicious anemia patients by a physician are recommended. If any symptoms of intolerance to TL-HEM 150, including but not limited to nausea, vomiting, abdominal cramps or rash occur, the drug should be discontinued, as determined by a physician. Biotin levels higher than the recommended daily allowance may cause interference with some la Baca dokumen lengkapnya